BSB Labs

BSB Labs (Bio-Science-Business Labs) is a biotechnology company specializing in the development of next-generation exosome-based therapeutics. The company utilizes its proprietary Exo-Target platform to engineer exosomes for precise drug delivery, enabling the transport of various payloads including small molecules, proteins, and nucleic acids to specific tissues. BSB Labs focuses on high-unmet-need areas such as oncology and immunology, aiming to overcome the limitations of traditional delivery systems. The company operates with a dual presence in South Korea and the United States, leveraging global expertise in extracellular vesicle research. BSB Labs also functions as a venture studio, fostering innovation through strategic collaborations and incubation of early-stage biotech projects.